Rech
Bernd Rech, Berlin DE
Patent application number | Description | Published |
---|---|---|
20080296262 | Process and Device for Cleaning and Etching a Substrate Wi - A simple process is disclosed for treating substrates having pre-structured zinc oxide layers on rigid or flexible supports. The ZnO is treated with an etching medium then with a cleaning liquid. The treatment with the etching and cleaning liquids is carried out while the substrate is conveyed through a device. The process is technically simple to implement and makes it possible to regularly and homogeneously roughen and texturise ZnO layers of up to 1 m | 12-04-2008 |
20110126886 | THIN-FILM SOLAR MODULE WHICH IS CONTACT-CONNECTED ON ONE SIDE AND HAS AN INTERNAL CONTACT LAYER - A thin-film solar module contacted on one side includes a support layer, a photoactive absorber layer and at least one dopant layer deposited over a surface area of at least one side of the absorber layer so as to form a thin-film packet that is divided into thin-film solar cell areas by insulating separating trenches. The thin-film solar module includes first and second contact systems. The first contact system includes contacts connected by an outer contact layer. The second contact system consists of an inner contact layer covering a side of the solar cell areas that face away from the support layer so as to separately discharge excess charge carriers generated by incident light in the absorber layer. The second contact system includes structures that surround and electrically insulate the contacts, which extend through the inner contact layer from the outer contact layer. The first and second contact systems are electrically conductive and connected in series by series contacts in interconnection areas and electrically insulated from each other by an insulation layer outside of the interconnection areas. | 06-02-2011 |
20110284062 | METHOD FOR THE DEPOSITION OF MICROCRYSTALLINE SILICON ON A SUBSTRATE - Disclosed is a method for depositing microcrystalline silicon on a substrate in a plasma chamber system, comprising the following steps: prior to initiating the plasma, providing the plasma chamber system with at least one reactive, silicon-containing gas and hydrogen, or exclusively hydrogen; initiating the plasma; after the plasma is initiated, continuously supplying the chamber system exclusively with reactive, silicon-containing gas, or after the plasma is initiated, continuously supplying the chamber system with at least one mixture comprising a reactive, silicon-containing gas and hydrogen, wherein the concentration of reactive, silicon-containing gas during the supply into the chamber is adjusted to greater than 0.5%; adjusting the plasma power to between 0.1 and 2.5 W/cm | 11-24-2011 |
20120073647 | SOLAR CELL COMPRISING NEIGHBORING ELECTRICALLY INSULATING PASSIVATION REGIONS HAVING HIGH SURFACE CHARGES OF OPPOSING POLARITIES AND PRODUCTION METHOD - A solar cell includes a photoactive, semiconductive absorber layer configured to generate excess charge carriers of opposed polarity by light incident on a front of the absorber layer during operation. The absorber layer is configured to separate and move, via at least one electric field formed in the absorber layer, the photogenerated excess charge carriers of opposed polarity over a minimal effective diffusion length L | 03-29-2012 |
20140213044 | METHOD FOR PRODUCING PERIODIC CRYSTALLINE SILICON NANOSTRUCTURES - A method for producing periodic crystalline silicon nanostructures of large surface area by: generating a periodic structure having a lattice constant of between 100 nm and 2 μm on a substrate, the substrate used being a material which is stable at up to at least 570° C., and the structure being produced with periodically repeating shallow and steep areas/flanks, and, subsequently, depositing silicon by directed deposition onto the periodically structured substrate, with a thickness in the range from 0.2 to 3 times the lattice constant, or 40 nm to 6 μm, at a substrate temperature of up to 400° C., followed by thermally treating the deposited Si layer to effect solid-phase crystallization, at temperatures between 570° C. and 1400° C., over a few minutes up to several days, and optionally subsequently wet-chemically selective etching to remove resultant porous regions of the Si layer. | 07-31-2014 |
Bernd Rech, Aachen DE
Patent application number | Description | Published |
---|---|---|
20080274582 | Method of Making Silicon Solar Cells Containing μC Silicon Layers - The invention relates to a method for producing solar cells comprising at least one p-i-n layer sequence containing micro-crystalline layers with the aid of a PECVD method. Said method is characterised in that all layers of the p-i-n layer sequence are deposited in a single-chamber process. The electrodes are interspaced at a distance of between 5 and 15 mm and the gas is distributed by means of a shower-head gas inlet, which guarantees a homogeneous distribution of the gas over the substrate. SiH | 11-06-2008 |
Bryan Rech, Boulder, CO US
Patent application number | Description | Published |
---|---|---|
20100152839 | Shape Memory Polymer Prosthetic Medical Device - A prosthetic medical device is formed by the combination of a biological tissue a shape memory polymer structure. The biological tissue provides an in-situ physiological function of the device. The shape memory polymer provides a capability for minimizing the device profile during insertion and then deploying after placement into a memory shape that achieves suitable mechanical structure and stability within an anatomical lumen or cavity. This configuration may be applied to form various prosthetic devices including aortic, mitral, and tricuspid valves in the heart; venous valves; anti-reflux valves for the lower esophageal sphincter; and other biological valve structures. Alternatively, an entirely non-biologic implementation using only shape memory polymer-based structures may be used as a prosthetic valve device. | 06-17-2010 |
20120203160 | IMPLANTS FOR REDUCING INTRAOCULAR PRESSURE - The present invention provides ocular implants adapted to reside in Schlemm's canal for reducing intraocular pressure of an eye and methods for using the same. In some embodiments the ocular implants comprise a thin rod adapted and configured to extend in a curved volume in Schlemm's canal. The thin rod comprises a plurality of wave-shaped segments such that a sufficient number and amount of wave-shaped segments extend to the inner wall of the trabecular meshwork and to the outer wall of Schlemm's canal thereby keeping Schlemm's canal open. | 08-09-2012 |
20120232648 | IMPLANTATION OF SHAPE MEMORY POLYMER INTRAOCULAR DEVICES - A shape memory polymer (SMP) intraocular lens may have a refractive index above 1.45, a Tg between 10° C. and 60° C., inclusive, de minimis or an absence of glistening, and substantially 100% transmissivity of light in the visible spectrum. The intraocular lens is then rolled at a temperature above Tg of the SMP material. The intraocular device is radially compressed within a die to a diameter of less than or equal to 1.8 mm while maintaining the temperature above Tg. The compressed intraocular lens device may be inserted through an incision less than 2 mm wide in a cornea or sclera or other anatomical structure. The lens can be inserted into the capsular bag, the ciliary sulcus, or other cavity through the incision. The SMP can substantially achieve refractive index values of greater than or equal to 1.45. | 09-13-2012 |
20120232651 | SHAPE MEMORY POLYMER INTRAOCULAR LENSES - A shape memory polymer (SMP) intraocular lens may have a refractive index above 1.45, a Tg between 10° C. and 60° C., inclusive, de minimis or an absence of glistening, and substantially 100% transmissivity of light in the visible spectrum. The intraocular lens is then rolled at a temperature above Tg of the SMP material. The intraocular device is radially compressed within a die to a diameter of less than or equal to 1.8 mm while maintaining the temperature above Tg. The compressed intraocular lens device may be inserted through an incision less than 2 mm wide in a cornea or sclera or other anatomical structure. The lens can be inserted into the capsular bag, the ciliary sulcus, or other cavity through the incision. The SMP can substantially achieve refractive index values of greater than or equal to 1.45. | 09-13-2012 |
20130165949 | SOFT TISSUE COAPTOR AND DEVICE FOR DEPLOYING SAME - A soft tissue coaptor and a soft tissue coaptor deployment device are disclosed which deliver a soft tissue coaptor or clip to a desired location for tissue repair. The soft tissue coaptor and soft tissue coaptor deployment device have particular application in surgical and microsurgical settings such as cardiac, vascular, and ophthalmic surgery. | 06-27-2013 |
20130267887 | AQUEOUS HUMOR MICRO-BYPASS SHUNTS - A small shunt can be placed within the eye to aid in drainage of aqueous humor from the anterior chamber of the eye to a pocket between the conjunctiva and the sclera to be absorbed, or to secrete through the cornea or the sclera external to the eye for glaucoma or ocular hypertension treatment. This drainage can decrease the pressure of the eye and potentially modify the course of advancing glaucomatous optic neuropathy as it relates to eye pressure. The shunt is formed of a shape memory polymer material and deformed into a smaller form factor to reduce trauma to the eye resulting from the insertion of the shunt through the sclera to the anterior chamber. Once in situ, the shunt deploys in response to body heat or other external stimulus and expands to its original, larger form factor to provide a secure friction fit of the shunt within the scleral tissue and to enlarge the lumen of the shunt to allow for aqueous flow. | 10-10-2013 |
20140172094 | SHAPE MEMORY POLYMER INTRAOCULAR LENSES - A shape memory polymer (SMP) intraocular lens may have a refractive index above 1.45, a Tg between 10° C. and 60° C., inclusive, de minimis or an absence of glistening, and substantially 100% transmissivity of light in the visible spectrum. The intraocular lens is then rolled at a temperature above Tg of the SMP material. The intraocular device is radially compressed within a die to a diameter of less than or equal to 1.8 mm while maintaining the temperature above Tg. The compressed intraocular lens device may be inserted through an incision less than 2 mm wide in a cornea or sclera or other anatomical structure. The lens can be inserted into the capsular bag, the ciliary sulcus, or other cavity through the incision. The SMP can substantially achieve refractive index values of greater than or equal to 1.45 | 06-19-2014 |
20140232025 | MANUFACTURING METHOD FOR SHAPE MEMORY POLYMER INTRAOCULAR DEVICES - A shape memory polymer (SMP) intraocular lens may have a refractive index above 1.45, a Tg between 10° C. and 60° C., inclusive, de minimis or an absence of glistening, and substantially 100% transmissivity of light in the visible spectrum. The intraocular lens is then rolled at a temperature above Tg of the SMP material. The intraocular device is radially compressed within a die to a diameter of less than or equal to 1.8 mm while maintaining the temperature above Tg. The compressed intraocular lens device may be inserted through an incision less than 2 mm wide in a cornea or sclera or other anatomical structure. The lens can be inserted into the capsular bag, the ciliary sulcus, or other cavity through the incision. The SMP can substantially achieve refractive index values of greater than or equal to 1.45. | 08-21-2014 |
Bryan Andrew Rech, Boulder, CO US
Patent application number | Description | Published |
---|---|---|
20130218178 | MEDICAL FABRIC WITH INTEGRATED SHAPE MEMORY POLYMER - Formulations of shape memory polymer (SMP) are integrated with several existing clinically available medical fabrics. The SMP portion of a SMP-integrated fabric can be fabricated in varying thicknesses with the minimum thickness determined by the thickness of the underlying fabric and up to almost any thickness. A large variety of patterns may be formed in SMP-integrated fabrics based upon how the shape memory polymer is integrated into the base fabric. Integration of the SMP with the base fabrics does not alter the shape memory functionality of the SMP. The design tools for controlling activation rate for traditional SMP materials thus apply to SMP-integrated fabrics. SMP-integrated fabrics may also be steam sterilized without loss of shape memory functionality. By using multiple formulations of SMP on a single piece of fabric, a large combination of material properties may be provided within a single SMP-integrated fabric device. | 08-22-2013 |
Christophe Rech, Grezy Sur Aix FR
Patent application number | Description | Published |
---|---|---|
20100089732 | ELECTRICAL SWITCH APPARATUS HAVING TWO INTERRUPTERS, SUCH AS A BUSBAR DISCONNECTOR AND A GROUNDING DISCONNECTOR, AND INCLUDING COMMON ACTUATOR MEANS FOR THE MOVABLE CONTACTS OF THE INTERRUPTERS - A switch apparatus comprising two interrupters, such as a busbar disconnector and a grounding disconnector. Common actuator means are provided for the movable contacts of the interrupters, for permitting one of the interrupters to be opened while holding the other interrupter closed, and vice versa, which enables the strokes performed by the movable contacts to be crossed. | 04-15-2010 |
Dietmar Rech, Oberwesel DE
Patent application number | Description | Published |
---|---|---|
20140161640 | PUMP - A pump includes a pump chamber in which a rotor with gates is supported so that it can rotate, an electric motor for driving the rotor, a muffler that encloses a volume in the area of the pump chamber, wherein the volume is in active connection with an outlet port and a front muffler that is arranged within the muffler. To improve the service life and reliability of the pump in a vehicle with minimal installation expense, it is proposed that a filter is integrated into the front muffler. | 06-12-2014 |
20140169992 | PUMP - A pump includes a pump chamber in which a rotor with gates is supported so that it can rotate, an electric motor for driving the rotor, an outlet, and an inlet port that is fastened to a mounting plate and is in active connection with an inlet channel. The pump should be improved so that its service life and reliability are improved with minimal installation complexity in a vehicle, wherein intense cleaning of lines and devices connected on the suction side can be eliminated. This is achieved in that a filter is arranged in the area of the inlet channel between the mounting plate and the pump chamber. | 06-19-2014 |
Elibio Leopoldo Rech, Brasilia - Df BR
Patent application number | Description | Published |
---|---|---|
20140206851 | PROTEINS FROM THE WEBS OF NEPHILENGYS CRUENTATA, AVICULARIA JURUENSIS AND PARAWIXIA BISTRIATA SPIDERS ISOLATED FROM BRAZILIAN BIODIVERSITY - The Present invention relates to molecules isolated from the nucleic acid that encodes spider web proteins or fragments of these or other derivatives of these. The invention also refers to a chimerical gene and an expression vector containing molecules isolated from the nucleic acid that codes for proteins related to the webs of | 07-24-2014 |
Gene Rech, Cedarburg, WI US
Patent application number | Description | Published |
---|---|---|
20150196155 | Sausage and Bun Packaging System and Method - A food container includes a base having a bottom wall and defining a longitudinal axis. A cover covers the base above the bottom wall. At least two bun supports on opposite sides of the longitudinal axis are provided and define a space therebetween for receiving an elongated food item substantially parallel to the longitudinal axis. The bun supports can support a bun above the elongated food item. | 07-16-2015 |
Gilberto Rech, Rossano Veneto (vicenza) IT
Patent application number | Description | Published |
---|---|---|
20110174843 | SPRAYER FOR LIQUIDS - A sprayer for liquids ( | 07-21-2011 |
Gilberto Rech, Roassano Veneto IT
Patent application number | Description | Published |
---|---|---|
20140319244 | SPRAYER FOR LIQUIDS WITH PRECOMPRESSION CHAMBER - A description is given of a sprayer of liquids ( | 10-30-2014 |
Jason Rech, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20120083474 | HETEROCYCLIC AMIDES AS MODULATORS OF TRPA1 - Certain heterocyclic amide compounds are described. The compounds may be used in pharmaceutical compositions and methods for treating disease states, disorders, and conditions mediated by TRPA1 activity, such as pain, arthritis, itch, cough, asthma, or inflammatory bowel disease. | 04-05-2012 |
Jason C. Rech, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090156599 | Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1 - Certain TRPV1-modulating imidazolo-, oxazolo-, and thiazolopyrimdine compounds are described. The compounds may be used in pharmaceutical compositions and methods for treating disease states, disorders, and conditions mediated by TRPV1 activity, such as pain, arthritis, itch, cough, asthma, or inflammatory bowel disease. | 06-18-2009 |
20130005687 | IMIDAZOLO-, OXAZOLO-, AND THIAZOLOPYRIMIDINE MODULATORS OF TRPV1 - Certain TRPV1-modulating imidazolo-, oxazolo-, and thiazolopyrimdine compounds are described. The compounds may be used in pharmaceutical compositions and methods for treating disease states, disorders, and conditions mediated by TRPV1 activity, such as pain, arthritis, itch, cough, asthma, or inflammatory bowel disease. | 01-03-2013 |
20140107098 | IMIDAZOLO-, OXAZOLO-, AND THIAZOLOPYRIMIDINE MODULATORS OF TRPV1 - Certain TRPV1-modulating imidazolo-, oxazolo-, and thiazolopyrimdine compounds are described. The compounds may be used in pharmaceutical compositions and methods for treating disease states, disorders, and conditions mediated by TRPV1 activity, such as pain, arthritis, itch, cough, asthma, or inflammatory bowel disease. | 04-17-2014 |
20140275096 | P2X7 MODULATORS - The present invention is directed to a compound of Formula (I) | 09-18-2014 |
Jason Christopher Rech, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20110092481 | QUINOLINE OR ISOQUINOLINE SUBSTITUTED P2X7 ANTAGONISTS - The present invention is related to novel compounds of formula (I) having P2X7 antagonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment or prophylaxis of diseases associated with P2X7 receptor activity in animals, in particular humans. (I) | 04-21-2011 |
Matthias Rech, Schwetzingen DE
Patent application number | Description | Published |
---|---|---|
20110278827 | REBOUND STRAP FOR AN AIRBAG COVER AND METHOD FOR PRODUCING A TRIM PART - A trim part has an airbag cover that opens in a hinged fashion. The trim part includes a retaining element that is connected on a first end to the airbag cover and on a second end to an anchor such that the retaining element has an excess length. At least one of the two ends is connected to a strip that includes webs that extend from the strip and that take up at least part of the excess length. | 11-17-2011 |
Pascale Rech, Le Rouret FR
Patent application number | Description | Published |
---|---|---|
20120310658 | METHOD AND SYSTEM FOR DYNAMIC PROFILE STRUCTURE HANDLING AND MANAGEMENT - A method and system for creating a dynamic profile structure for managing and handling transactions between a travel agent and a customer, where the transactions require a plurality of predefined fields to be entered by a user to instigate a transaction are disclosed. The disclosed method includes developing via a computer a model of a geographical structure for use with any user, which geographical structure includes a number of levels and nodes. The method further includes defining via a computer a first profile structure for each node which includes a plurality of predetermined geographical fields specific to each level or node. The method further includes developing via a computer a model of a second structure associated with the customer requirements, which second structure includes a number of nodes, such as countries. The method further includes defining via a computer a second profile structure for each node which includes a plurality of predetermined second fields specific to each node. The method further includes forming via a computer a combined profile structure for a first use case from the plurality of geographical fields and the plurality of second fields based on a customer defined requirement. | 12-06-2012 |
20140019175 | Method and system for dynamic profile structure handling and management - Method and system for creating a dynamic profile structure for managing and handling transactions between a travel agent and a customer, where the transactions require a plurality of predefined fields to be entered by a user to instigate a transaction are disclosed. A model of a geographical structure is developed for use with any user, which geographical structure includes a number of levels and nodes. A first profile structure is defined for each node and includes predetermined geographical fields specific to each level or node. A model of a second structure associated with the customer requirements is developed. The second structure includes a number of nodes, such as countries. A second profile structure is defined for each node and includes predetermined second fields specific to each node. A combined profile structure is defined from the geographical fields and the second fields based on a customer defined requirement. | 01-16-2014 |
Richard H. Rech, Okemos, MI US
Patent application number | Description | Published |
---|---|---|
20100227876 | Methods of Reducing Side Effects of Analgesics - The invention provides for compositions and methods of reducing pain in a subject by administering a combination of mu-opioid receptor agonist, kappa1-opioid receptor agonist and a nonselective opioid receptor antagonist in amounts effective to reduce pain and ameliorate an adverse side effect of treatment combining opioid-receptor agonists. The invention also provides for methods of enhancing an analgesic effect of treatment with an opioid-receptor agonist in a subject suffering from pain while reducing an adverse side effect of the treatment. The invention also provides for methods of reducing the hyperalgesic effect of treatment with an opioid-receptor agonist in a subject suffering from pain while reducing an adverse side effect of the treatment. The invention further provides for methods of promoting the additive analgesia of pain treatment with an opioid-receptor agonist in a subject in need while reducing an adverse side effect of the treatment. | 09-09-2010 |
Silvano Rech, Seren Del Grappa IT
Patent application number | Description | Published |
---|---|---|
20110129379 | METHOD FOR MANUFACTURING MASSIVE COMPONENTS MADE OF INTERMETALLIC MATERIALS - The invention relates to a method for manufacturing a massive component substantially wholly made of intermetallic material, comprising the steps of: | 06-02-2011 |
Thomas Rech, Rittersheim DE
Patent application number | Description | Published |
---|---|---|
20120084316 | DATABASE-TRANSPARENT NEAR ONLINE ARCHIVING AND RETRIEVAL OF DATA - Method, program products and apparatus are disclosed for optimizing access to a data table. A value-existence structure is used to determine whether the data table contains rows for a given database query. The value-existence structure may be useful, for example, for managing transparent access to an online database and a nearline database. | 04-05-2012 |
20130198857 | PROCESSING OF RESTRICTED ACCESS DATA - Embodiments related to processing of restricted-access data. An aspect includes receiving a request for data from a user by a storage system infrastructure comprising a centralized database that stores non-restricted access data and a local system that stores restricted-access data associated with a first set of areas or entities and comprising a federated database for providing a federated view, wherein the requested data comprises restricted-access first data and non-restricted access second data. Another aspect includes based on an association of the user, routing, by a routing entity, the request to the local system. Another aspect includes receiving the request at the at least one federated database of the local system. Another aspect includes retrieving from the federated database the restricted-access first data and the non-restricted access second data. Another aspect includes displaying the federated view comprising the restricted-access first data and the non-restricted access second data to the user. | 08-01-2013 |